Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Succinylated Gelatin Injection for ANH in Elective Surgery
NCT06977763Not yet recruiting
- Sponsor
- Nanjing Chia-Tai Tianqing Pharmaceutical
- Start
- Jul 2025
- Primary completion
- Nov 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
01
Overview
Randomised, double-blind trial of gelofusine + sodium chloride in hypovolemia (2 arms), sponsored by Nanjing Chia-Tai Tianqing Pharmaceutical. Primary endpoint: Change in Stroke Volume. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
gelofusine + sodium chloride
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NCT06977763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06977763.